Status:
UNKNOWN
Facial Block for Outpatient Rhinoplasty Analgesia
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Outpatient Rhinoplasty
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
A bilateral facial block (infraorbital and infratrochlear) will be performed immediately after intubation in patients undergoing outpatient rhinoplasty with 2.5% levobupivacaine (intervention group) o...
Eligibility Criteria
Inclusion
- Outpatient rhinoplasty
- American Society of Anesthesiologists (ASA) classification I-II
- Affiliated to Social Security
- Written informed consent
Exclusion
- Allergy to levobupivacaine
- Incapacity to give consent
- Chronic pain
Key Trial Info
Start Date :
June 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2014
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT01872728
Start Date
June 1 2013
End Date
December 1 2014
Last Update
March 18 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Edouard Herriot
Lyon, France